Search Results - "Grebely, J"

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience by Marshall, A.D., Grebely, J., Dore, G.J., Treloar, C.

“…•Overall, participants found engagement in hepatitis C care a rewarding experience.•Practitioners require further hepatitis C testing and liver disease staging…”
Get full text

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011 by Iversen, J., Grebely, J., Topp, L., Wand, H., Dore, G., Maher, L.

“…Summary The majority of new and existing cases of hepatitis C virus (HCV) infection occur among people who inject drugs (PWID). Despite safe and efficacious…”
Get full text

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia by Hajarizadeh, B., Grebely, J., Matthews, G. V., Martinello, M., Dore, G. J.

“…Summary A government‐funded interferon‐free direct‐acting antiviral (DAA) treatment programme for chronic hepatitis C virus (HCV) infection has been available…”
Get full text

The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs by Rance, J., Grebely, J., Treloar, C.

“…Australia has made considerable progress towards the public-health 'elimination' of the hepatitis C virus. Nonetheless, reinfection remains a key challenge,…”
Get full text

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study by Cunningham, E. B., Hajarizadeh, B., Bretana, N. A., Amin, J., Betz‐Stablein, B., Dore, G. J., Luciani, F., Teutsch, S., Dolan, K., Lloyd, A. R., Grebely, J., Haber, Paul, Rawlinson, William, Treloar, Carla, Maher, Lisa

“…Summary Hepatitis C virus (HCV) transmission is high in prisons. This study investigated trends in HCV incidence and associated factors among a cohort of…”
Get full text

Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study by Treloar, C., Rance, J., Dore, G. J., Grebely, J.

“…Summary Provision of hepatitis C virus (HCV) assessment and treatment via opioid substitution treatment (OST) clinics has been posed as an effective means of…”
Get full text

‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective by Marshall, AD, Rance, J, Grebely, J, Treloar, C

“…To achieve hepatitis C viral (HCV) elimination targets set by the World Health Organisation, pillars of the HCV care cascade are often referenced to track…”
Get full text

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents by Grebely, J., Raffa, J. D., Lai, C., Krajden, M., Kerr, T., Fischer, B., Tyndall, M. W.

“…Despite the availability of effective therapy for hepatitis C virus (HCV) infection, there are little data on the uptake of treatment. We evaluated factors…”
Get full text

HCV reinfection incidence among individuals treated for recent infection by Martinello, M., Grebely, J., Petoumenos, K., Gane, E., Hellard, M., Shaw, D., Sasadeusz, J., Applegate, T. L., Dore, G. J., Matthews, G. V.

“…Summary One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this analysis was to calculate the incidence of HCV…”
Get full text

Patterns and Characteristics of Hepatitis C Transmission Clusters among HIV-Positive and HIV-Negative Individuals in the Australian Trial in Acute Hepatitis C by Matthews, G. V., Pham, S. T., Hellard, M., Grebely, J., Zhang, L., Oon, A., Marks, P., van Beek, I., Rawlinson, W., Kaldor, J. M., Lloyd, A., Dore, G. J., White, P. A.

“…Background. Injecting drug users remain the population at greatest risk of acquiring hepatitis C virus (HCV) infection, although a recent increase in case of…”
Get full text

“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting by Lafferty, L., Rance, J., Byrne, M., Milat, A., Dore, G.J., Grebely, J., Lloyd, A.R., Treloar, C.

“…Hepatitis C (HCV) is highly prevalent among people who are incarcerated. HCV treatment-as-prevention was implemented in the SToP-C trial in four correctional…”
Get full text

Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel by Lafferty, L., Rance, J., Dore, G.J., Grebely, J., Lloyd, A.R., Treloar, C.

“…Hepatitis C (HCV) infection is prevalent in the prison setting, with sharing of unsterile injecting equipment the most common mode of transmission in high…”
Get full text

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection by Martinello, M., Bhagani, S., Gane, E., Orkin, C., Cooke, G., Dore, G. J., Petoumenos, K., Applegate, T. L., Tu, E., Marks, P., Pagani, N., Grebely, J., Nelson, M., Matthews, G. V.

“…Summary Paritaprevir/ritonavir/ombitasvir and dasabuvir with or without ribavirin for 12 weeks are approved for treatment of chronic HCV genotype 1 infection…”
Get full text

Addressing reimbursement disparities for direct-acting antiviral therapies for hepatitis C virus infection is essential to ensure access for all by Grebely, J., Litwin, A., Dore, G. J.

Get full text

The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments by Hajarizadeh, B, Grebely, J, Matthews, G.V, Martinello, M, Dore, G.J

Get full text

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study by Alavi, M., Janjua, N. Z., Chong, M., Grebely, J., Aspinall, E. J., Innes, H., Valerio, H., Hajarizadeh, B., Hayes, P. C., Krajden, M., Amin, J., Law, M. G., George, J., Goldberg, D. J., Hutchinson, S. J., Dore, G. J.

“…Summary This study evaluates trends in hepatitis C virus (HCV)‐related hepatocellular carcinoma (HCC) incidence and survival in three settings, prior to…”
Get full text

A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies by Bartlett, S. R., Wertheim, J. O., Bull, R. A., Matthews, G. V., Lamoury, F. M. J., Scheffler, K., Hellard, M., Maher, L., Dore, G. J., Lloyd, A. R., Applegate, T. L., Grebely, J.

“…Summary Combining phylogenetic and network methodologies has the potential to better inform targeted interventions to prevent and treat infectious diseases…”
Get full text

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study by Conway, A., Valerio, H., Peacock, A., Degenhardt, L., Hayllar, J., Harrod, ME, Henderson, C., Read, P., Gilliver, R., Christmass, M., Dunlop, A., Montebello, M., Whitton, G., Reid, D., Lam, T., Alavi, M., Silk, D., Marshall, AD, Treloar, C., Dore, GJ, Grebely, J.

“…•Recent benzodiazepine and hazardous alcohol use is associated with opioid overdose.•Naloxone coverage is low among people at risk of overdose.•Two thirds of…”
Get full text

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia by Grebely, J., Bryant, J., Hull, P., Hopwood, M., Lavis, Y., Dore, G. J., Treloar, C.

“…Assessment and treatment for hepatitis C virus (HCV) in the community remains low. We evaluated factors associated with HCV specialist assessment and treatment…”
Get full text

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach by Jacka, B., Bray, B. C., Applegate, T. L., Marshall, B. D. L., Lima, V. D., Hayashi, K., DeBeck, K., Raghwani, J., Harrigan, P. R., Krajden, M., Montaner, J. S. G., Grebely, J.

“…Summary This study estimated latent classes (ie, unobserved subgroups in a population) of people who use drugs in Vancouver, Canada, and examined how these…”
Get full text